Business / Finance

RSS

NYSE-Amex accepts CorMedix's plan to regain compliance with continued listing standards

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, announces the receipt of notice on June 27, 2012 from the NYSE Amex LLC, that the NYSE-Amex has accepted the CorMedix's plan to regain compliance with continued listing standards of the NYSE-Amex.

3 Jul 2012

MedCath completes sale of BHH to CCG

MedCath Corporation announced that it entered into a definitive equity purchase agreement and completed the sale of its 53.31% equity interest in Bakersfield Heart Hospital ("BHH") and its secured loans to BHH to Cardiovascular Care Group.

3 Jul 2012

LTC acquires skilled nursing property in Brownwood, Texas

LTC Properties, Inc. announced today that it acquired a skilled nursing property with 90 licensed beds for $6.5 million. The property is located in Brownwood, Texas and was built in 2011.

3 Jul 2012

NOVA Plastic Surgery of Reston, Virginia unveils new logo and tagline

NOVA Plastic Surgery of Reston, Virginia, has just unveiled a new tagline to represent the NOVA brand. The new tagline, "It's Still You, Only Better," signifies NOVA's commitment to preserving the unique beauty of each person, while helping them look and feel their best.

3 Jul 2012

Catalyst Health Solutions, SXC complete merger

SXC Health Solutions Corp., a leading provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry, announces that it has completed its previously disclosed merger of Catalyst Health Solutions, Inc. with a wholly-owned subsidiary of SXC.

3 Jul 2012

CCG announces acquisition of Bakersfield Heart Hospital

The Cardiovascular Care Group (CCG) today announced it has finalized the acquisition of a majority interest in the Bakersfield (California) Heart Hospital from MedCath Corporation.

2 Jul 2012

One Equity Partners to acquire M*Modal

M*Modal, a leading provider of clinical documentation services and Speech Understanding solutions, and One Equity Partners today announced that they have entered into a definitive agreement pursuant to which One Equity Partners, the private investment arm of JP Morgan Chase & Co., will acquire all of the outstanding shares of M*Modal for $14.00 per share in an all-cash transaction.

2 Jul 2012

Palatin announces private placement of common stock and warrants

Palatin Technologies, Inc. today announced that it has entered into a definitive securities agreement and priced a private placement of 3,873,000 shares of its common stock, Series A warrants to purchase 31,988,151 shares of its common stock, and Series B warrants to purchase 35,488,380 shares of its common stock.

2 Jul 2012

Community Health Systems acquires Memorial Health Systems in York

Community Health Systems, Inc. announced today that subsidiaries of the Company have acquired substantially all of the assets of Memorial Health Systems in York, Pennsylvania.

2 Jul 2012

Bristol-Myers Squibb to acquire Amylin

Bristol-Myers Squibb Company and Amylin Pharmaceuticals, Inc. announced today that Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or an aggregate purchase price of approximately $5.3 billion.

2 Jul 2012

BIOREM announces proposed private placement of $1.5 million

BIOREM Inc. is pleased to announce a proposed private placement of up to 1,500 Units at a price per Unit of $1,000 for gross proceeds of up to $1.5 million. Each Unit will consist of $1,000 principal amount of 8.00% convertible extendible secured subordinated debentures with a maturity date 2 years from the date of issuance and 4,545 common share purchase warrants.

30 Jun 2012

Unilife prices underwritten offering of 6,154,000 shares of common stock

Unilife Corporation today announced the pricing of its underwritten offering of 6,154,000 shares of common stock at a price of $3.25 per share.

29 Jun 2012

KKR to acquire up to 63% ownership stake in GenesisCare

GenesisCare and Kohlberg Kravis Roberts & Co. L.P. announced that agreements have been entered into under which KKR will acquire up to a 63% ownership stake in GenesisCare, subject to shareholder acceptance.

28 Jun 2012

Cigna enters agreement with Humana to purchase Medicare Advantage plans in Texas, Arkansas

Cigna today announced that it has come to an agreement with Humana to purchase select Medicare Advantage plans in Texas and Arkansas. The plans in the three markets - Amarillo, Longview-Marshall and Texarkana - are part of a previously announced government-stipulated divestiture for Humana to complete its acquisition of Arcadian Health.

28 Jun 2012

Covidien acquires Oridion Systems

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today said that it has completed the previously announced acquisition of Oridion Systems Ltd. for an aggregate consideration of approximately $310 million, net of cash and investments acquired.

26 Jun 2012

Report on the global market for breast cancer diagnostics and drug technologies

Breast Cancer Diagnostic and Drug market are recovering after significant slowdown during the global recession. Having accurate market data and analysis will be essential to companies seeking to compete on the global stage as the market reemerges into success.

26 Jun 2012

Merck Serono, Compugen announce establishment of Neviah Genomics

Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen Ltd. today announced the establishment of Neviah Genomics, a novel start-up company focused on the discovery and development of novel biomarkers for the prediction of drug-induced toxicity.

26 Jun 2012

CHRI signs new sales LOI with Pengxi Huitong Pharmaceutical

China Health Resource, Inc., announced today that it has signed a new sales letter of intent (LOI) for this year for its proprietary Yishen Capsule valued at 25 million RMB; approximately $4 million USD.

26 Jun 2012

Affymetrix acquires eBioscience

Affymetrix Inc., today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc., a privately-held company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics.

26 Jun 2012

NIH awards SeKON contract under CIO-SP3 restricted solicitation

SeKON Enterprise, Inc., a leader in enterprise business applications and management consulting, announced today that the National Institutes of Health (NIH) has awarded the company a contract under its Chief Information Officer - Solutions and Partners 3 (CIO-SP3) restricted solicitation.

25 Jun 2012